European Archives - Page 924 of 1369 - European Medical Journal

Sebaceous Carcinoma: A Rare Extraocular Presentation of the Cheek

Sebaceous carcinoma is a rare and very aggressive malignant skin cancer of the sebaceous gland. While sebaceous glands are present all over the body…

Best supporting role: patient organisations

In pharma’s bid to be patient centric, it must bring the patient voice to the drug development process with the help of medical affairs.

Integrating wellness into pharma's patient approach

The transition from reactive to proactive treatments correlates with society’s new-found focus on well-being, and the pharma industry must embrace wellness and adapt to steamroll this into improved overall outcomes for patients.

An Interview with Prof Alberto Arezzo at UEG Week Barcelona 2019

We spoke to Prof Alberto Arezzo (UEG Scientific Committee Member) at UEG Week 2019, Barcelona, Spain, where he discussed developments in surgical…

Patient Data: Opting In or Out?

At one point in time, our world’s most valuable commodity was oil. Fast forward to the digital age and that accolade is held by data. Free-flowing rivers of it double up as life sources that all industries, including the pharmaceutical industry, have become dependent on. However, as consumers learn the true value of their own information, the broken dam of data is patched up with privacy laws.

An Interview with Rodrigo Gribble from AstraZeneca

We met with Rodrigo Gribble, Vice President, Cardiovascular, AstraZeneca, who discussed his experience working with emerging markets, the recent successes…

Managing Follicular Lymphoma

Practical Insights into Managing Follicular Lymphoma: What’s Best for Patients?

The first case focussed on a 56-year-old female economist, who presented with abdominal discomfort that led to a CT scan evaluation where lymph node…

Managing Follicular Lymphoma

EMJ Hematology 8 [Suppl 1] 2020

The symposium “Practical Insights into Managing Follicular Lymphoma: What’s Best for Patients?” took place at the 24th European Hematology Association…

Talking to Emma Clayton

Emma Clayton, CEO, Grey Bear Consultancy, talks about the journey to starting her own agency, pharma communications in the COVID-19 era, and empowering women to succeed in the workplace.

Keeping Frankenstein’s Monster at Bay

I am not a fatalist, I do not believe things happen for a reason, but I do believe we can find reason in the things that happen…